Clinical determinants of social media use in individuals with schizophrenia

Autoři: Gurpreet Rekhi aff001;  Mei San Ang aff001;  Jimmy Lee aff001
Působiště autorů: Research Division, Institute of Mental Health, Singapore, Singapore aff001;  North Region & Department of Psychosis, Institute of Mental Health, Singapore, Singapore aff002;  Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore aff003
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: 10.1371/journal.pone.0225370


This study aimed to examine the prevalence of social media use and its association with symptoms in individuals with schizophrenia. 265 individuals with schizophrenia were assessed. Symptoms were assessed on the Positive and Negative Syndrome Scale (PANSS) and the Clinical Assessment Interview for Negative Symptoms (CAINS). Information on social media use was collected. Logistic regressions were used to explore the association between social media use and socio-demographic and clinical characteristics of the participants. Of the 265 study participants, 139 (52.5%) used social media in the last week. Fifty-six (21.1%) of the study participants used more than one social media site in the last week. Facebook was the most popular social media site. Age, highest education level, monthly household income, PANSS negative and depression factor scores were significantly associated with social media use. Amongst negative symptoms, the CAINS motivation-pleasure (MAP) social factor scores were found to be significantly associated with social media use. Our study results suggested that the assessment of social interactions via social media should be considered in the clinical assessment of individuals with schizophrenia. Secondly, our results suggested that the development of treatment programs supported by social media platforms may be useful for certain groups of individuals with schizophrenia. Younger patients with above secondary level education, higher family income and lower symptom severity are likely to be avid users of social media and would be suitable candidates to receive illness related information or clinical interventions via social media.

Klíčová slova:

Educational attainment – Facebook – Internet – Mental health and psychiatry – Motivation – Schizophrenia – Singapore – Social media


1. Social Media Fact Sheet 2019 [cited 2019 Sep 4]. Available from:

2. Digital in 2019 Singapore [Internet]: We Are Social. 2019. [cited 2019 Sep 4]. Available from:

3. Bonet L, Llacer B, Hernandez M, Arce D, Blanquer I, Cañete C, et al. S249. IS INTERNET HARMFUL FOR PSYCHOTIC PATIENTS? Schizophrenia bulletin. 2018;44(suppl_1):S424–S. doi: 10.1093/schbul/sby018.1036

4. Brusilovskiy E, Townley G, Snethen G, Salzer MS. Social Media Use, Community Participation and Psychological Well-being Among Individuals with Serious Mental Illnesses. Comput Hum Behav. 2016;65(C):232–40. doi: 10.1016/j.chb.2016.08.036

5. Naslund JA, Aschbrenner KA, Bartels SJ. How people with serious mental illness use smartphones, mobile apps, and social media. Psychiatr Rehabil J. 2016;39(4):364–7. Epub 06/16. doi: 10.1037/prj0000207 27845533.

6. Trefflich F, Kalckreuth S, Mergl R, Rummel-Kluge C. Psychiatric patients' internet use corresponds to the internet use of the general public. Psychiatry Res. 2015;226(1):136–41. doi: 10.1016/j.psychres.2014.12.037 25623020

7. Birnbaum ML, Rizvi AF, Confino J, Correll CU, Kane JM. The role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders. Early Interv Psychiatry. 2017;11(4):290–5. doi: 10.1111/eip.12237 25808317; PubMed Central PMCID: PMC4580496.

8. Gowen K, Deschaine M, Gruttadara D, Markey D. Young adults with mental health conditions and social networking websites: seeking tools to build community. Psychiatr Rehabil J. 2012;35(3):245–50. doi: 10.2975/35.3.2012.245.250 22246123

9. McKenna KYA, Green AS, Gleason MEJ. Relationship Formation on the Internet: What’s the Big Attraction? Journal of Social Issues. 2002;58(1):9–31. doi: 10.1111/1540-4560.00246

10. Alvarez-Jimenez M, Bendall S, Lederman R, Wadley G, Chinnery G, Vargas S, et al. On the HORYZON: moderated online social therapy for long-term recovery in first episode psychosis. Schizophrenia research. 2013;143(1):143–9. doi: 10.1016/j.schres.2012.10.009 23146146.

11. Miller BJ, Stewart A, Schrimsher J, Peeples D, Buckley PF. How connected are people with schizophrenia? Cell phone, computer, email, and social media use. Psychiatry Res. 2015;225(3):458–63. doi: 10.1016/j.psychres.2014.11.067 25563669

12. Kaneko K. Negative Symptoms and Cognitive Impairments in Schizophrenia: Two Key Symptoms Negatively Influencing Social Functioning. Yonago Acta Med. 2018;61(2):91–102. doi: 10.33160/yam.2018.06.001 29946215

13. Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World psychiatry: official journal of the World Psychiatric Association (WPA). 2017;16(1):14–24. doi: 10.1002/wps.20385 28127915

14. First MB, Spitzer, Robert L, Gibbon Miriam, and Williams, Janet B.W. Structured Clinical Interview for DSM-!V-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometric Research, New York State Psychiatric Institute2002.

15. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia bulletin. 1987;13(2):261–76. doi: 10.1093/schbul/13.2.261 3616518.

16. Jiang J, Sim K, Lee J. Validated five-factor model of positive and negative syndrome scale for schizophrenia in Chinese population. Schizophrenia research. 2013;143(1):38–43. doi: 10.1016/j.schres.2012.10.019 23148897

17. Forbes C, Blanchard JJ, Bennett M, Horan WP, Kring A, Gur R. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia research. 2010;124(1–3):36–42. doi: 10.1016/j.schres.2010.08.039 20869848; PubMed Central PMCID: PMC2981616.

18. Horan WP, Kring AM, Gur RE, Reise SP, Blanchard JJ. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia research. 2011;132(2–3):140–5. doi: 10.1016/j.schres.2011.06.030 21798716; PubMed Central PMCID: PMC3196271.

19. Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry. 2013;170(2):165–72. doi: 10.1176/appi.ajp.2012.12010109 23377637; PubMed Central PMCID: PMC3785242.

20. Rekhi G, Ang MS, Yuen CKY, Ng WY, Lee J. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore. Schizophrenia research. 2019;206:177–82. doi: 10.1016/j.schres.2018.11.029 30558979

21. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean? Schizophrenia research. 2005;79(2–3):231–8. doi: 10.1016/j.schres.2005.04.008 15982856

22. Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16(1):14–24. doi: 10.1002/wps.20385 28127915; PubMed Central PMCID: PMC5269507.

23. Millan MJ, Fone K, Steckler T, Horan WP. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. Eur Neuropsychopharmacol. 2014;24(5):645–92. doi: 10.1016/j.euroneuro.2014.03.008 24820238.

24. Horan WP, Subotnik KL, Snyder KS, Nuechterlein KH. Do recent-onset schizophrenia patients experience a "social network crisis"? Psychiatry. 2006;69(2):115–29. doi: 10.1521/psyc.2006.69.2.115 16822191

25. Hirschberg W. [Social networks in schizophrenic disorders—a review]. Psychiatr Prax. 1988;15(3):84–9. 3043521

26. Strauss GP. The emotion paradox of anhedonia in schizophrenia: or is it? Schizophrenia bulletin. 2013;39(2):247–50. doi: 10.1093/schbul/sbs192 23328158; PubMed Central PMCID: PMC3576151.

27. Conley RR, Ascher-Svanum H, Zhu B, Faries D, Kinon BJ. The Burden of Depressive Symptoms in the Long-Term Treatment of Patients With Schizophrenia. Schizophrenia research. 2007;90(1–3):186–97. doi: 10.1016/j.schres.2006.09.027 17110087

28. Gozdzik-Zelazny A, Borecki L, Pokorski M. Depressive symptoms in schizophrenic patients. Eur J Med Res. 2011;16(12):549–52. doi: 10.1186/2047-783X-16-12-549 22112362

29. Steger MF, Kashdan TB. Depression and Everyday Social Activity, Belonging, and Well-Being. Journal of counseling psychology. 2009;56(2):289–300. doi: 10.1037/a0015416 20428460

30. Bonet L, Llácer B, Hernandez-Viadel M, Arce D, Blanquer I, Cañete C, et al. Differences in the Use and Opinions About New eHealth Technologies Among Patients With Psychosis: Structured Questionnaire. JMIR Ment Health. 2018;5(3):e51. doi: 10.2196/mental.9950 30045835

31. Schrank B, Sibitz I, Unger A, Amering M. How patients with schizophrenia use the internet: qualitative study. J Med Internet Res. 2010;12(5):e70–e. doi: 10.2196/jmir.1550 21169176.

32. Dohrenwend BP. Socioeconomic status (SES) and psychiatric disorders. Are the issues still compelling? Soc Psychiatry Psychiatr Epidemiol. 1990;25(1):41–7. doi: 10.1007/bf00789069 2406949.

33. Kuruvilla A, Jacob KS. Poverty, social stress & mental health. The Indian journal of medical research. 2007;126(4):273–8. 18032802.

34. Harvey PD, Heaton RK, Carpenter WT Jr., Green MF, Gold JM, Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophrenia research. 2012;140(1–3):1–8. doi: 10.1016/j.schres.2012.03.025 22503642; PubMed Central PMCID: PMC3399960.

35. Spinzy Y, Nitzan U, Becker G, Bloch Y, Fennig S. Does the Internet offer social opportunities for individuals with schizophrenia? A cross-sectional pilot study. Psychiatry Res. 2012;198(2):319–20. doi: 10.1016/j.psychres.2012.02.022 22440545

36. van de Mortel T. Faking it: social desirability response bias in self-report research. Australian Journal of Advanced Nursing. 2008:40–8.

Článek vyšel v časopise


2019 Číslo 11